Natixis Advisors L.P. Buys 170,536 Shares of Doximity, Inc. (NASDAQ:DOCS)

Natixis Advisors L.P. raised its stake in Doximity, Inc. (NASDAQ:DOCS) by 48.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 522,115 shares of the company’s stock after purchasing an additional 170,536 shares during the period. Natixis Advisors L.P. owned approximately 0.28% of Doximity worth $14,640,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. First Horizon Advisors Inc. raised its position in shares of Doximity by 111.3% during the fourth quarter. First Horizon Advisors Inc. now owns 995 shares of the company’s stock valued at $28,000 after buying an additional 524 shares during the last quarter. Victory Capital Management Inc. raised its holdings in Doximity by 21.3% in the 4th quarter. Victory Capital Management Inc. now owns 32,863 shares of the company’s stock valued at $921,000 after acquiring an additional 5,780 shares in the last quarter. Russell Investments Group Ltd. raised its holdings in Doximity by 47.7% in the 4th quarter. Russell Investments Group Ltd. now owns 84,266 shares of the company’s stock valued at $2,363,000 after acquiring an additional 27,226 shares in the last quarter. GAMMA Investing LLC bought a new stake in shares of Doximity in the 4th quarter worth approximately $40,000. Finally, Linden Thomas Advisory Services LLC grew its holdings in shares of Doximity by 2.0% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 40,758 shares of the company’s stock worth $1,143,000 after purchasing an additional 793 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Price Performance

NASDAQ DOCS opened at $24.60 on Tuesday. The stock’s 50 day simple moving average is $26.45 and its 200 day simple moving average is $26.32. Doximity, Inc. has a one year low of $19.71 and a one year high of $36.29. The firm has a market cap of $4.59 billion, a PE ratio of 33.46, a price-to-earnings-growth ratio of 3.03 and a beta of 1.18.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings data on Thursday, February 8th. The company reported $0.25 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.06. Doximity had a return on equity of 16.08% and a net margin of 29.39%. The company had revenue of $135.28 million for the quarter, compared to analyst estimates of $127.46 million. As a group, equities analysts expect that Doximity, Inc. will post 0.72 earnings per share for the current year.

Insiders Place Their Bets

In other Doximity news, Director Kira Scherer Wampler sold 2,500 shares of the company’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $26.97, for a total transaction of $67,425.00. Following the transaction, the director now owns 10,258 shares of the company’s stock, valued at approximately $276,658.26. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 39.40% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Evercore ISI restated an “in-line” rating and issued a $30.00 target price on shares of Doximity in a research note on Tuesday, April 2nd. JPMorgan Chase & Co. raised shares of Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 price objective for the company in a report on Thursday, April 25th. Wells Fargo & Company upped their target price on shares of Doximity from $25.00 to $27.00 and gave the company an “equal weight” rating in a research note on Friday, February 9th. Morgan Stanley reissued an “underweight” rating and issued a $25.00 price target on shares of Doximity in a research report on Tuesday, April 23rd. Finally, Truist Financial lifted their price objective on Doximity from $28.00 to $29.00 and gave the company a “hold” rating in a report on Friday, February 9th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Doximity presently has an average rating of “Hold” and an average target price of $28.82.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.